Cardiovascular Ultrasound or imaging allows healthcare professionals to monitor changes in heart structure to detect the presence of any abnormality or medical conditions such as diabetes, hypertension or other cardiovascular diseases. The global cardiovascular ultrasound market is estimated to strike a CAGR of 6.3% over the forecast period of 2017-2023, predicts Market Research Future (MRFR). After extensively analyzing the market MRFR expects the Global Cardiovascular Ultrasound Market to attain a valuation of USD 1.72 Bn by the end of 2027 which stood at USD 1.45 Bn in 2016.
Cardiovascular diseases continue to be among the top reasons for hospitalization and deaths across the globe. Surging prevalence of heart diseases requires early detection of such diseases to allow physicians to provide timely treatment. The global cardiovascular ultrasound market is expanding against the backdrop of an alarming increase in the incidence rate of heart diseases.
Cardiovascular ultrasound techniques such as echocardiography, angiography, nuclear cardiac imaging, computed tomography, cardiac positron emission tomography (cardiac PET) and cardiac magnetic resonance imaging (cardiac MRI) are extensively used for the determination of any abnormalities. Not only are these methods effective but also non-invasive which has led to increased adoption of these methods.
Philips Healthcare (The Netherlands), Toshiba Medical Systems Corporation (Japan), Siemens Healthcare (Germany), Hitachi Medical Corporation (Japan), and GE Healthcare (U.S.) are the key players in the global Cardiovascular Ultrasound Market Share
Industry Updates:
July 2018 – The U.S. FDA cleared a new device for transesophageal echocardiogram, TEECAD System. The device has been developed by Visura Technologies, a medical device company which allows viewing the upper airway and esophagus. The device is equipped with a single-use disposable camera which can capture high-resolution ultrasound images of the heart valves and atria.
Global Cardiovascular Ultrasound Market – Segmentation
The Global Cardiovascular Ultrasound Market has been segmented based on type of imaging, imaging technology, and end user.
By type of imaging, the global cardiovascular ultrasound market has been segmented into transthoracic, trans esophageal, echocardiograms, stress, and abdominal vasculature ultrasound imaging.
By imaging technology, the global cardiovascular ultrasound market has been segmented into 2D, 3D and Color Doppler.
By end user, the global cardiovascular ultrasound market has been segmented into hospitals and clinics, diagnostic centers and others.
Global Cardiovascular Ultrasound Market – Regional Analysis
By region, the Global Cardiovascular Ultrasound Market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
North America is the largest market for cardiovascular ultrasound market. High prevalence of cardiovascular diseases and robust healthcare infrastructure supports the growth of the market in the region. Moreover, high healthcare expenditure, favorable reimbursement policies, and the presence of various medical device manufacturers in the region also acts as a plus for the growth of the market.
APAC is expected to be the fastest growing market for cardiovascular ultrasound market. Surging prevalence of cardiovascular diseases and the presence of a massive patient pool are factors driving growth within the APAC market. In addition, diabetes is also a common prevalent condition in the region which exposes patients at greater risk of acquiring heart diseases. High expenditure on healthcare infrastructure and government support for the same us fostering the growth of the market in the region.
Browse Complete 80 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/cardiovascular-ultrasound-market-1548
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Global Pulmonary Atresia Diagnostics and Treatment Market: Type (Intact Ventricular Septum, Ventricular Septum Defect), Diagnosis (Pulse Oximetry, Echocardiogram), Treatment (Medication, Surgery), End-Users (Hospitals, Clinics)–Global Forecast Till 2027Market HighlightsA pulmonary atresia is a form of birth disease where the pulmonary valve which controls the flow of blood from the right ventricle to the pulmonary artery does not work effectively.
In some cases, babies with pulmonary atresia may also have a small or missing, right ventricle that cannot properly pump blood to the lungs.
In the case of pulmonary atresia, there is no threat to life, while the fetus is developing because the placenta is used to provide oxygen to the baby when the lungs are not functioning.
Only after birth, the symptoms are noted and if the newborn baby turns blue or grey in color when the maternal source of oxygen is detached, it indicates that the newborn is suffering from the disease.However, unspecified regulatory issues, infection risks connected with surgical procedures, and ambiguous reimbursement policies are the factors limiting the market growth.SegmentationThe global pulmonary atresia diagnostics and treatment market has been segmented on the basis of type, diagnosis, treatment and end users.On the basis of type, the market has been classified as pulmonary atresia with an intact ventricular septum and pulmonary atresia with ventricular septum defect.
The cardiac catheterization is segmented into radiofrequency ablation and balloon valvotomy, balloon atrial septostomy, and stent placement.
The surgery is segmented into right ventricular outflow reconstruction, blalock-taussig shunt, bi-directional glenn procedure, fontan procedure, and heart transplant.
The Global Cardiac MRI Testing System Market Report is prepared to club all the essential market details such as market size, share, value, growth, restraints, challenges, and opportunities during the study period of 2020-2026.
The detailed content of the market study ensures intellectual insights given a better understanding of the untapped opportunities in the market.Access Full Report with Table of Contents @ https://www.decisiondatabases.com/ip/46162-cardiac-mri-testing-systems-industry-market-reportThe major vendors covered:General Electric CompanyMedtronicKoninklijke Philips N.VSiemens HealthcareCanon Medical Systems CorporationBrukerHitachi Medical SystemsMindrayNeusoft Medical SystemsSegment by Type, the Cardiac MRI Testing Systems market is segmented intoOpen MRI SystemClosed MRI SystemSegment by Application, the Cardiac MRI Testing Systems market is segmented intoHospitalClinicDiagnostic Imaging CenterOtherRegional and Country-level AnalysisThe Cardiac MRI Testing Systems market is analysed and market size information is provided by regions (countries).The key regions covered in the Cardiac MRI Testing Systems market report are North America, Europe, China and Japan.
It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.The report includes country-wise and region-wise market size for the period 2015-2026.
It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.Competitive Landscape and Cardiac MRI Testing Systems Market Share AnalysisCardiac MRI Testing Systems market competitive landscape provides details and data information by manufacturers.
The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Cardiac MRI Testing Systems by the player for the period 2015-2020.
It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020.
Market Analysis and Insights: Ambulatory Healthcare IT MarketAmbulatory Healthcare IT Market By Type (Ambulatory Services, Primary Care Offices, Outpatient Departments, Emergency Departments, Surgical Specialty, Medical Specialty, Others), Modality (Hospital-affiliated, Freestanding), Surgery Type (Opthalmology, Orthopedics, Gastroenterology, Pain Management, Others), Application (Laceration Treatment, Bone Fracture Treatment, Emergency Care Service, Trauma Treatment), Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa) - Industry Trends and Forecast to 2026Global ambulatory healthcare IT market is registering a substantial CAGR in the forecast period of 2019-2026.
This rise in the market value can be attributed to the growing incidence of chronic diseases and continuous advancement in technologies.If you are an investor/shareholder in Ambulatory Healthcare IT Market, the provided study will help you to understand the growth model Ambulatory Healthcare IT Market after the impact of COVID-19.
Request for sample report@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ambulatory-healthcare-marketMarket Definition: Global Ambulatory Healthcare IT MarketAmbulatory care is also referred as outpatient care.
The report includes market shares of ambulatory healthcare IT market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.Market DriversGrowing incidence of chronic diseases, is driving the market growthContinuous technological advancement, is flourishing the market growthRising geriatric population, is helping the market to growRising demand for minimally invasive surgeries, drives the market growthMarket RestraintsInadequate communication, hinders the market growthPrevalence of adverse drug activities, hampers the market growthDelayed diagnostic, acts as a market restraintsSegmentation: Global Ambulatory Healthcare IT MarketBy TypeAmbulatory ServicesPrimary Care OfficesOutpatient DepartmentsEmergency DepartmentsSurgical SpecialtyOphthalmologyOrthopedicsGastroenterologySpinal InjectionsPlastic SurgeryOthersMedical SpecialtyOthersBy ModalityHospital-affiliatedFreestandingBy Surgery TypeOpthalmologyOrthopedicsGastroenterologyPain ManagementOthersBy ApplicationLaceration TreatmentBone Fracture TreatmentEmergency Care ServiceTrauma TreatmentBy GeographyNorth AmericaU.S.CanadaMexicoSouth AmericaBrazilRest of South AmericaEuropeGermanyFranceUnited KingdomItalySpainRussiaTurkeyBelgiumNetherlandsSwitzerlandRest of EuropeAsia-PacificJapanChinaSouth KoreaIndiaAustraliaSingaporeMalaysiaIndonesiaThailandPhilippinesRest of Asia-PacificMiddle East & AfricaSouth AfricaRest of Middle East & AfricaInquire before the purchasing report –@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ambulatory-healthcare-marketKey Developments in the Market:In January 2017, Arterys received FDA allowance for Arterys Cardio DL.
Arterys Cardio DL is the first analytics cloud software for zero-footprint medical imaging with complete study for cardiac MRI.
Key Market Competitors:Few of the major market competitors currently working in the global ambulatory healthcare IT market are AmSurg Corp, Surgical Care Affiliates, Surgery Partners, Healthway Medical Group, SurgCenter, Trillium Health Partners, Medical Facilities Corporation, Nueterra Capital, Aspen Healthcare, Suomen Terveystalo Oy, IntegraMed America, Inc., SHERIDAN HEALTHCARE, NueHealth, Athenahealth, GENERAL ELECTRIC, Optum, Inc., Apria Healthcare Group, Inc., DaVita Inc., LVL Medical, Fresenius Kabi AG, Sonic Healthcare among others.Research Methodology: Global Ambulatory Healthcare IT MarketData collection and base year analysis is done using data collection modules with large sample sizes.
